4//SEC Filing
Grissinger Michael 4
Accession 0001104659-24-073936
CIK 0001781983other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:16 PM ET
Size
7.4 KB
Accession
0001104659-24-073936
Insider Transaction Report
Form 4
Grissinger Michael
Director
Transactions
- Award
Common Stock
2024-06-20+1,045→ 1,844 total - Award
Stock Options (Right to Buy)
2024-06-20+4,185→ 4,185 totalExercise: $4.07Exp: 2034-06-20→ Common Stock (4,185 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on June 20, 2024, and which will vest and be settled in common stock on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F2]The option vests in full on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001757601
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:16 PM ET
- Size
- 7.4 KB